<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01921101</url>
  </required_header>
  <id_info>
    <org_study_id>685</org_study_id>
    <nct_id>NCT01921101</nct_id>
    <nct_alias>NCT01071330</nct_alias>
  </id_info>
  <brief_title>Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT)</brief_title>
  <acronym>INTACT</acronym>
  <official_title>Intensive Nutrition in ARDS: A Clinical Trail (INTACT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a prospective randomized clinical trail to evaluate the impact of
      intensive medical nutrition therapy (IMNT) in patients with acute respiratory distress
      syndrome (ARDS) or acute lung injury (ALI) on short and long-term outcomes. Participant's (N
      = 200) will be randomized to receive either standard care (SC e.g. ad lib feeding of standard
      food) or IMNT provided early as enteral nutrition (EN) and continued as intensive diet
      therapy tailored to maximize oral intake until hospital discharge. Primary outcomes evaluated
      include infections while hospitalized, immune parameters (CD4 and CD8 cells, serum IL-10 and
      leptin levels, numbers of T regulatory cells and markers for T cell anergy), days on
      mechanical ventilation, in the ICU and hospital , and changes in fat free mass(measured by
      dual energy x-ray absorptiometry), weight, muscular weakness (measured as hand grip
      strength), fatigue (measured as distanced traveled in 6-minute walk) and pulmonary function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was terminated early due to greater deaths occurring in the intervention group vs
      the control group. There were a total of 22 deaths, 16 in the intervention and 6 in the
      control.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    greater mortality in intervention group
  </why_stopped>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infection</measure>
    <time_frame>Assessed daily from study enrollment through hospital discharge, an average of 3 weeks</time_frame>
    <description>All new infections that occurred (including blood, wound, sputum, urinary tract and pulmonary) from enrollment through hospital discharge recorded in the medical record were counted</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>days in hospital</time_frame>
    <description>The total number of days the patient is in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on Mechanical Ventilation</measure>
    <time_frame>days</time_frame>
    <description>the total number of days requiring mechanical ventilation while hospitalized</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>date of occurence</time_frame>
    <description>The date of death for all participants that die between enrollment and their final data collection, 24 weeks following hospital discharge</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Immune Parameters</measure>
    <time_frame>baseline and weekly while hospitalized</time_frame>
    <description>Markers of immune response (including IL-6, IL-10, adiponectin, leptin, CRP, TNF, CD4/CD8 and HLA/CD14</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Acute Lung Injury</condition>
  <arm_group>
    <arm_group_label>intensive medical nutrition</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>participants will receive intensive medical nutrition from hospital admission to discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>participants will not receive intensive nutritional support from hospital admission to discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>intensive medical nutrition</intervention_name>
    <description>provision of participants energy and protein needs via enteral, parenteral nutrition from hospital admission to discharge</description>
    <arm_group_label>intensive medical nutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>participants will receive standard care for nutrition received from hospital admission to discharge</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Adult patients (&gt; 18 years) with a diagnosis of acute lung injury, with
        viable GI function for enteral feeding

        Exclusion Criteria: Patients who are (1) transferred from another ICU, (2) previously
        admitted to the ICU during the same hospitalization, (3) do not resuscitate status or &lt; 12
        month perceived survival due to underlying disease state (4) severely immunosuppressed, (5)
        immobility prior to ICU admission, (6) documented neurological disease prior to admission.
        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>carol l braunschweig, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sheean PM, Peterson SJ, Chen Y, Liu D, Lateef O, Braunschweig CA. Utilizing multiple methods to classify malnutrition among elderly patients admitted to the medical and surgical intensive care units (ICU). Clin Nutr. 2013 Oct;32(5):752-7. doi: 10.1016/j.clnu.2012.12.012. Epub 2013 Jan 5.</citation>
    <PMID>23340043</PMID>
  </reference>
  <reference>
    <citation>Sheean PM, Peterson SJ, Zhao W, Gurka DP, Braunschweig CA. Intensive medical nutrition therapy: methods to improve nutrition provision in the critical care setting. J Acad Nutr Diet. 2012 Jul;112(7):1073-9. doi: 10.1016/j.jand.2012.02.007. Epub 2012 May 12.</citation>
    <PMID>22579721</PMID>
  </reference>
  <reference>
    <citation>Peterson SJ, Sheean PM, Braunschweig CL. Orally fed patients are at high risk of calorie and protein deficit in the ICU. Curr Opin Clin Nutr Metab Care. 2011 Mar;14(2):182-5. doi: 10.1097/MCO.0b013e3283428e65. Review.</citation>
    <PMID>21178611</PMID>
  </reference>
  <reference>
    <citation>Braunschweig CA, Sheean PM, Peterson SJ. Examining the role of nutrition support and outcomes for hospitalized patients: putting nutrition back in the study design. J Am Diet Assoc. 2010 Nov;110(11):1646-9. doi: 10.1016/j.jada.2010.08.019.</citation>
    <PMID>21034876</PMID>
  </reference>
  <reference>
    <citation>Sheean PM, Peterson SJ, Gurka DP, Braunschweig CA. Nutrition assessment: the reproducibility of subjective global assessment in patients requiring mechanical ventilation. Eur J Clin Nutr. 2010 Nov;64(11):1358-64. doi: 10.1038/ejcn.2010.154. Epub 2010 Aug 11.</citation>
    <PMID>20700137</PMID>
  </reference>
  <reference>
    <citation>Peterson SJ, Tsai AA, Scala CM, Sowa DC, Sheean PM, Braunschweig CL. Adequacy of oral intake in critically ill patients 1 week after extubation. J Am Diet Assoc. 2010 Mar;110(3):427-33. doi: 10.1016/j.jada.2009.11.020.</citation>
    <PMID>20184993</PMID>
  </reference>
  <results_reference>
    <citation>Braunschweig CA, Sheean PM, Peterson SJ, Gomez Perez S, Freels S, Lateef O, Gurka D, Fantuzzi G. Intensive nutrition in acute lung injury: a clinical trial (INTACT). JPEN J Parenter Enteral Nutr. 2015 Jan;39(1):13-20. doi: 10.1177/0148607114528541. Epub 2014 Apr 9.</citation>
    <PMID>24722769</PMID>
  </results_reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2013</study_first_submitted>
  <study_first_submitted_qc>August 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2013</study_first_posted>
  <results_first_submitted>April 15, 2014</results_first_submitted>
  <results_first_submitted_qc>April 15, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 14, 2014</results_first_posted>
  <last_update_submitted>August 1, 2014</last_update_submitted>
  <last_update_submitted_qc>August 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Carol Braunschweig</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>nutrition</keyword>
  <keyword>enteral feeding</keyword>
  <keyword>parenteral feeding</keyword>
  <keyword>hospital malnutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intensive Medical Nutrition</title>
          <description>participants will receive intensive medical nutrition from hospital admission to discharge
intensive medical nutrition: provision of participants energy and protein needs via enteral, parenteral nutrition from hospital admission to discharge</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>participants will not receive intensive nutritional support from hospital admission to discharge
control: participants will receive standard care for nutrition received from hospital admission to discharge</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>gender, race/ethnicity, age, diagnosis, admission height and weight, body mass index, ICU admission Acute Physiology and Chronic Health Evaluation II score, Sequential Organ Failure Assessment scores</population>
      <group_list>
        <group group_id="B1">
          <title>Intensive Medical Nutrition</title>
          <description>participants will receive intensive medical nutrition from hospital admission to discharge
intensive medical nutrition: provision of participants energy and protein needs via enteral, parenteral nutrition from hospital admission to discharge</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>participants will not receive intensive nutritional support from hospital admission to discharge
control: participants will receive standard care for nutrition received from hospital admission to discharge</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.5" spread="17.1"/>
                    <measurement group_id="B2" value="58.6" spread="16.2"/>
                    <measurement group_id="B3" value="55.4" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acute Physiology and Chronic Health Evaluation II (APACHE II)</title>
          <description>The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a severity-of-disease classification. It is applied within 24 hours of admission to the intensive care unit. The scores range from 0-71; higher scores correspond to more severe disease and a higher risk of death</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.4" spread="9.3"/>
                    <measurement group_id="B2" value="27.7" spread="7.9"/>
                    <measurement group_id="B3" value="25.5" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sequential Organ Functional Assessment (SOFA)</title>
          <description>The sequential organ failure assessment score (SOFA)is a scoring system used in critically ill patients to assess the extent of their organ function. The total score is based on six different scores, one of the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. These scores range from 0-24; higher scores indicate more severe organ compromise.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.3" spread="3.8"/>
                    <measurement group_id="B2" value="9.4" spread="3.4"/>
                    <measurement group_id="B3" value="9.3" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>body mass index</title>
          <description>Body mass index was calculated based on admission weight (Kg)/ height (m)2; NIH classifications for BMI categories were used ( BMI &lt; 18.5 malnourished; 18.5-24.9 normal weight, 25-29.9 overweight and &gt; 30 obese)</description>
          <units>Kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.8" spread="9.3"/>
                    <measurement group_id="B2" value="30.1" spread="8.9"/>
                    <measurement group_id="B3" value="30" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Infection</title>
        <description>All new infections that occurred (including blood, wound, sputum, urinary tract and pulmonary) from enrollment through hospital discharge recorded in the medical record were counted</description>
        <time_frame>Assessed daily from study enrollment through hospital discharge, an average of 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Nutrition</title>
            <description>participants will receive intensive medical nutrition from hospital admission to discharge
intensive medical nutrition: provision of participants energy and protein needs via enteral, parenteral nutrition from hospital admission to discharge</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>participants will not receive intensive nutritional support from hospital admission to discharge
control: participants will receive standard care for nutrition received from hospital admission to discharge</description>
          </group>
        </group_list>
        <measure>
          <title>Infection</title>
          <description>All new infections that occurred (including blood, wound, sputum, urinary tract and pulmonary) from enrollment through hospital discharge recorded in the medical record were counted</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.29</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>The total number of days the patient is in the hospital</description>
        <time_frame>days in hospital</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days on Mechanical Ventilation</title>
        <description>the total number of days requiring mechanical ventilation while hospitalized</description>
        <time_frame>days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death</title>
        <description>The date of death for all participants that die between enrollment and their final data collection, 24 weeks following hospital discharge</description>
        <time_frame>date of occurence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Nutrition</title>
            <description>participants will receive intensive medical nutrition from hospital admission to discharge
intensive medical nutrition: provision of participants energy and protein needs via enteral, parenteral nutrition from hospital admission to discharge</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>participants will not receive intensive nutritional support from hospital admission to discharge
control: participants will receive standard care for nutrition received from hospital admission to discharge</description>
          </group>
        </group_list>
        <measure>
          <title>Death</title>
          <description>The date of death for all participants that die between enrollment and their final data collection, 24 weeks following hospital discharge</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Immune Parameters</title>
        <description>Markers of immune response (including IL-6, IL-10, adiponectin, leptin, CRP, TNF, CD4/CD8 and HLA/CD14</description>
        <time_frame>baseline and weekly while hospitalized</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment throughout hospitalization in all participants, an average of 3 weeks</time_frame>
      <desc>hyperglycemia, hypoglycemia, aspiration, tube feeding complications, parenteral nutrition complications, death</desc>
      <group_list>
        <group group_id="E1">
          <title>Intensive Medical Nutrition</title>
          <description>participants will receive intensive medical nutrition from hospital admission to discharge
intensive medical nutrition: provision of participants energy and protein needs via enteral, parenteral nutrition from hospital admission to discharge</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>participants will not receive intensive nutritional support from hospital admission to discharge
control: participants will receive standard care for nutrition received from hospital admission to discharge</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>death</sub_title>
                <description>death from enrollment to 24 weeks post hospital discharge</description>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="40"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Carol Braunschweig, Professor</name_or_title>
      <organization>University of Illinois at Chicago</organization>
      <phone>3129962575</phone>
      <email>braunsch@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

